54 results on '"Ardissino, Diego"'
Search Results
2. Spontaneous coronary artery dissection: an Italian single centre experience
3. Abstract 16139: A Targeted Proteomic Approach to Identify Circulating Biomarkers of Heart Failure Risk in Patients With Type 2 Diabetes Mellitus in DECLARE-TIMI 58
4. Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling
5. Supplement to: Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia Investigators. Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease.
6. Impact of Selection Bias on Estimation of Subsequent Event Risk
7. Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease
8. Genetic testing in predicting the risk of sudden death
9. Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention
10. Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54
11. Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial
12. Supplement to: Inactivating mutations in NPC1L1 and protection from coronary heart disease.
13. Supplement to: Loss-of-function mutations in APOC3, triglycerides, and coronary disease.
14. New-generation drug-eluting stents reduce stent thrombosis and myocardial infarction: A propensity-score-adjusted analysis from the multicenter REAL registry (REgistro Regionale AngiopLastiche DellʼEmilia-Romagna)
15. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
16. Association of exome sequences with plasma C-reactive protein levels in >9000 participants
17. Adenosine-induced severe bronchospasm in a patient without pulmonary disease
18. Type D Personality in Never Depressed Patients at Their First Acute Coronary Syndrome
19. Optimal Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes: A Systematic Review and Meta-analysis
20. Poster session: Aortic stenosis
21. Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
22. Ejection Fraction Change and Coronary Artery Disease Severity: A Vasodilator Contrast Stress-Echocardiography Study
23. Acute coronary syndromes: considerations for improved acceptance and implementation of management guidelines
24. Clopidogrel response variability: Clinical applications
25. Twenty-four months clinical outcomes of sirolimus-eluting stents for the treatment of small coronary arteries: the long-term SES-SMART clinical study
26. Safety of contrast flash-replenishment stress echocardiography in 500 patients with a chest pain episode of undetermined origin within the last 5 days
27. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial
28. Prognostic value of computed tomography coronary angiography in patients with suspected coronary artery disease: a 24-month follow-up study
29. Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry
30. Contrast Stress Echocardiography for the Diagnosis of Coronary Artery Disease in Patients With Chest Pain but Without Acute Coronary Syndrome: Incremental Value of Myocardial Perfusion
31. Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: Results from a real-world multicenter registry
32. Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes
33. Summertime loneliness as a trigger for all variants of stress-cardiomyopathy in the elderly
34. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
35. †Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
36. Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up
37. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study
38. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study
39. Tirofiban in acute coronary syndromes
40. Sirolimus-Eluting vs Uncoated Stents for Prevention of Restenosis in Small Coronary Arteries: A Randomized Trial
41. Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and Aspirin: A Randomized Controlled Trial
42. Plasma and urinary free 3-nitrotyrosine following cardiac angiography procedures with non-ionic radiocontrast media
43. One-year follow-up of the ASSENT-2 trial: A double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction
44. Risk of Myocardial Infarction and Polymorphisms in Candidate Genes
45. Acute renal and hepatic failure due to accidental percutaneous absorption of 1,2-dichlorpropane contained in a commercial paint fixative
46. Mortality at 1 Year With Combination Platelet Glycoprotein IIb/IIIa Inhibition and Reduced-Dose Fibrinolytic Therapy vs Conventional Fibrinolytic Therapy for Acute Myocardial Infarction: GUSTO V Randomized Trial
47. Early non-invasive management of acute coronary syndromes
48. Low-dose fibrinolytics and glycoprotein IIb/IIIa receptor blockade for the treatment of acute myocardial infarction
49. Prognostic Value of the Admission Electrocardiogram in Acute Coronary Syndromes
50. Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: Experience from GUSTO-IIb
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.